Proteome Sciences (LON:PRM) Hits New 1-Year Low – Should You Sell?

Proteome Sciences plc (LON:PRM)’s share price hit a new 52-week low during trading on Monday. The stock traded as low as GBX 1.20 and last traded at GBX 1.21, with a volume of 107495 shares. The stock had previously closed at GBX 1.45.

Proteome Sciences Stock Performance

The company’s 50-day moving average price is GBX 1.66 and its two-hundred day moving average price is GBX 1.62. The company has a market cap of £4.24 million, a P/E ratio of -1.16 and a beta of 0.16. The company has a current ratio of 0.12, a quick ratio of 0.37 and a debt-to-equity ratio of -161.07.

Proteome Sciences (LON:PRM) last released its earnings results on Wednesday, September 16th. The company reported GBX (0.41) EPS for the quarter. Proteome Sciences had a positive return on equity of 23.85% and a negative net margin of 61.46%.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.